FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹318 Cr | ₹221 Cr | ₹155 Cr | ₹162 Cr | ₹207 Cr |
What is the latest Cash Flow from Operating Activities ratio of FDC ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹318 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹155 Cr |
| Mar2022 | ₹162 Cr |
| Mar2021 | ₹207 Cr |
How is Cash Flow from Operating Activities of FDC Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹318 Cr | 43.85 | |
| Mar2024 | ₹221 Cr | 42.51 | |
| Mar2023 | ₹155 Cr | -4.17 | |
| Mar2022 | ₹162 Cr | -21.94 | |
| Mar2021 | ₹207 Cr | - | |
Compare Cash Flow from Operating Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,610.1 Cr | -3.9% | -16.7% | -27.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -3.9% |
-16.7% |
-27.3% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses